These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions. Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023 [TBL] [Abstract][Full Text] [Related]
4. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA alterations of pancreatic intraepithelial neoplasias. Yu J; Li A; Hong SM; Hruban RH; Goggins M Clin Cancer Res; 2012 Feb; 18(4):981-92. PubMed ID: 22114139 [TBL] [Abstract][Full Text] [Related]
6. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
7. LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer. Nakata K; Ohuchida K; Nagai E; Hayashi A; Miyasaka Y; Kayashima T; Yu J; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M Neoplasia; 2009 Jul; 11(7):712-9. PubMed ID: 19568416 [TBL] [Abstract][Full Text] [Related]
8. p120 Catenin Suppresses Basal Epithelial Cell Extrusion in Invasive Pancreatic Neoplasia. Hendley AM; Wang YJ; Polireddy K; Alsina J; Ahmed I; Lafaro KJ; Zhang H; Roy N; Savidge SG; Cao Y; Hebrok M; Maitra A; Reynolds AB; Goggins M; Younes M; Iacobuzio-Donahue CA; Leach SD; Bailey JM Cancer Res; 2016 Jun; 76(11):3351-63. PubMed ID: 27032419 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia. Al-Aynati MM; Radulovich N; Riddell RH; Tsao MS Clin Cancer Res; 2004 Feb; 10(4):1235-40. PubMed ID: 14977820 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia. Park HU; Kim JW; Kim GE; Bae HI; Crawley SC; Yang SC; Gum JR; Batra SK; Rousseau K; Swallow DM; Sleisenger MH; Kim YS Pancreas; 2003 Apr; 26(3):e48-54. PubMed ID: 12657964 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
13. Exploring the Wnt pathway-associated LncRNAs and genes involved in pancreatic carcinogenesis driven by Tp53 mutation. Wang Q; Jiang H; Ping C; Shen R; Liu T; Li J; Qian Y; Tang Y; Cheng S; Yao W; Wang L Pharm Res; 2015 Mar; 32(3):793-805. PubMed ID: 24469904 [TBL] [Abstract][Full Text] [Related]
14. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745 [TBL] [Abstract][Full Text] [Related]
16. Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer. Ohya A; Yamanoi K; Shimojo H; Fujii C; Nakayama J Cancer Sci; 2017 Sep; 108(9):1897-1902. PubMed ID: 28685935 [TBL] [Abstract][Full Text] [Related]
17. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas. Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
19. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. van Heek NT; Meeker AK; Kern SE; Yeo CJ; Lillemoe KD; Cameron JL; Offerhaus GJ; Hicks JL; Wilentz RE; Goggins MG; De Marzo AM; Hruban RH; Maitra A Am J Pathol; 2002 Nov; 161(5):1541-7. PubMed ID: 12414502 [TBL] [Abstract][Full Text] [Related]
20. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Mazur PK; Einwächter H; Lee M; Sipos B; Nakhai H; Rad R; Zimber-Strobl U; Strobl LJ; Radtke F; Klöppel G; Schmid RM; Siveke JT Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13438-43. PubMed ID: 20624967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]